Nocturnal and exercise oxygen desaturation in COPD patients with and without OSAS Source: Annual Congress 2013 –Sleep disordered breathing in special situations III Year: 2013
COPD and OSA: Can the overlap syndrome be suspected by clinical symptoms Source: International Congress 2016 – Effect of sleep apnoea on life-span and comorbidities Year: 2016
Prevalence and predictive factors of sleep breathing disorders (SBD) in severe COPD patients Source: International Congress 2014 – Sleep disordered breathing 2 Year: 2014
Differences between patients with overlap syndrome (COPD + OSAS) and patients with OSAS Source: International Congress 2015 – Measuring sleep-disordered breathing in children and adults I: questionnaires, epidemiology and sleep studies Year: 2015
Can we use the oxygen desaturation index alone to reliably diagnose obstructive sleep apnoea in obese patients? Source: International Congress 2016 – Clinical presentation, daytime symptoms, and screening of obstructive sleep apnoea Year: 2016
Clinical significance of transcutaneous PCO2 in patients with obstructive sleep apnea syndrome Source: International Congress 2015 – Measuring sleep-disordered breathing in children and adults I: questionnaires, epidemiology and sleep studies Year: 2015
Use of clinical predictors on diagnosis of OSAS in patients with chronic obstructive pulmonary disease, asthma and cardiovascular diseases Source: International Congress 2014 – Sleep disordered breathing 3 Year: 2014
Patients with sleep apnoea(SA) and severe/difficult to treat asthma(SDTA) have worse asthma related clinical outcomes than those with no sleep apnoea Source: International Congress 2016 – Effect of sleep apnoea on life-span and comorbidities Year: 2016
Nocturnal hypoxemia and depression among out-patients COPD subjects: A case-control study Source: International Congress 2014 – Evaluating sleep disordered breathing in children and adults Year: 2014
The effect of physical rehabilitation (PR) on the severity of symptoms of OSAS in patients with chronic obstructive pulmonary disease (COPD) and obstructive sleep apnoea syndrome (OSA) Source: International Congress 2016 – New insights into pulmonary rehabilitation for chronic lung diseases Year: 2016
Prevalence, predictors and impact of nocturnal hypoxemia in non-apnoeic patients with COPD Source: International Congress 2015 – Clinical assessment in asthma and COPD Year: 2015
Functional effectiveness of auto-CPAP therapy in COPD patients with obstructive sleep apnea Source: International Congress 2016 – Noninvasive ventilation and beyond: novelties and real-life applications Year: 2016
Blood pressure indices in patients with obstructive sleep apnea and overlap syndrome Source: International Congress 2014 – Clinical problems in acute and chronic lung diseases Year: 2014
Albuminuria in moderate and severe obstructive sleep apnoea (OSA) patients Source: International Congress 2015 – Inflammation, biomarkers and hypoxia in sleep disordered breathing Year: 2015
Predictors of increased daytime sleepiness in patients with COPD Source: International Congress 2014 – Sleep disordered breathing 2 Year: 2014
The positive effect of CPAP therapy on the level of liver enzymes in obstructive sleep apnea patients Source: International Congress 2015 – Inflammation, biomarkers and hypoxia in sleep disordered breathing Year: 2015
Sleep quality in patients with asthma and COPD Source: International Congress 2015 – Clinical assessment in asthma and COPD Year: 2015
Clinical presentations of OSA in adults Source: Eur Respir Mon 2010; 50: 86-103 Year: 2010
Hypertension among obstructive sleep apnea patients compared to controls. Two year change after starting treatment with CPAP Source: Annual Congress 2013 –The heart of the matter: sleep disordered breathing Year: 2013
STOP-BANG questionnaire overestimates sleep apnea in asthmatic patients with nocturnal symptoms Source: International Congress 2016 – Clinical presentation, daytime symptoms, and screening of obstructive sleep apnoea Year: 2016